Two Discoveries by Zhejiang University Listed as "2016 Top 10 Scientific Achievements in Chinese Universities"


On December 26, the “2016 Top 10 Scientific Achievements in Chinese Universities” were officially unveiled by the Science and Technology Committee of China’s Ministry of Education. The project of “Theories and Approaches in Hybrid Intelligence Based on Brain-Computer Integration” led by Prof. Wu Zhaohui, and the project of “The Layered System of New Molecules in Liver Transplant for Liver Cancer Patients” led by Prof. Zheng Shusen, were awarded the coveted title.

The research team led by Prof. Wu Zhaohui and Prof. Zheng Xiaoxiang has engaged in research into brain-machine integration in the past decade. Researchers have pioneered in creating the research paradigm of “hybrid intelligence”―the fusion of biological intelligence and artificial intelligence―and has developed a series of groundbreaking theories and technologies. They maintain that deep integration between the perceptive and cognitive capacity of a living creature and the computational ability of a machine may give birth to a stronger intelligence form surpassing all existing systems. This discovery opens up brilliant vistas in rehabilitation of the physically challenged, rescue and relief work as well as national defense and security.    

The research team has become a trailblazer in “transplanting” the auditory and visual ability of a computer to a living creature in the world and building a ratbot with augmented auditory and visual abilities; it has also pioneered in using the human mind to control a mechanic hand in the game of ‘rock-paper-scissors’ in China; it has addressed the question as to whether brain-machine integration can enable a living creature to obtain learning enhancement. In the face of human diseases, it has developed a brain-computer self-adapted mechanism for the integration of ‘epilepsy prediction-inhibition by electric stimulation’.

The research team led by Prof. Zheng Shusen put forward Hangzhou criteria for liver transplant in 2008, which were the first to include the characteristics of the recipient in tumor biology and pathology globally. These criteria are labeled as a watershed in research into liver transplant. In 2016, the team carried out further research into 6,012 samples in China and found that Hangzhou criteria helped increase the transplantation probability for liver cancer patients by 52%. Meanwhile, the 5-year survivability rate amounted to 72.5%.

Hangzhou criteria have been adopted and substantiated by over 10 international transplant centers in western countries and thus been highly acclaimed as international criteria. World-renowned transplant teams, including UCLA, Cleveland Clinic and Tokyo University, have spoken in praise of these criteria as exceptionally excellent. Hangzhou criteria are China’s first medical standards to win international recognition in the organ transplant field.